APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Insulin Like Growth Factor 1 Receptor

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Insulin Like Growth Factor 1 Receptor Market Outlook and Growth Opportunities 2026

Report ID 174003610419 December 2025197 pages

Choose your research edition.

Industry ResearchInsulin Like Growth Factor 1 Receptor Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Like Growth Factor 1 Receptor Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Insulin Like Growth Factor 1 Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Like Growth Factor 1 Receptor Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Like Growth Factor 1 Receptor Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Insulin Like Growth Factor 1 Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Insulin Like Growth Factor 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Insulin Like Growth Factor 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Insulin Like Growth Factor 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Insulin Like Growth Factor 1 Receptor market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Insulin Like Growth Factor 1 Receptor market include Novartis AG, Merck & Co., Inc., Eli Lilly and Company, AstraZeneca Plc, ProteoThera, Inc., PharmAbcine, Inc., Merrimack Pharmaceuticals, Inc., Insmed Incorporated and Immunomedics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Insulin Like Growth Factor 1 Receptor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Insulin Like Growth Factor 1 Receptor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Insulin Like Growth Factor 1 Receptor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Insulin Like Growth Factor 1 Receptor market size, projected growth trends, production technologies, key applications, and end-use industries.

Insulin Like Growth Factor 1 Receptor Segment by Company

Novartis AG

Merck & Co., Inc.

Eli Lilly and Company

AstraZeneca Plc

ProteoThera, Inc.

PharmAbcine, Inc.

Merrimack Pharmaceuticals, Inc.

Insmed Incorporated

Immunomedics, Inc.

Genmab A/S

F. Hoffmann-La Roche Ltd.

Bristol-Myers Squibb Company

Boehringer Ingelheim GmbH

Axelar AB

Astellas Pharma Inc.

Insulin Like Growth Factor 1 Receptor Segment by Type

CT-707

BI-893923

ATL-1101

1R-E1

Others

Insulin Like Growth Factor 1 Receptor Segment by Application

Hospital

Clinic

Others

Insulin Like Growth Factor 1 Receptor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Insulin Like Growth Factor 1 Receptor status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Insulin Like Growth Factor 1 Receptor market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Insulin Like Growth Factor 1 Receptor significant trends, drivers, influence factors in global and regions.

6. To analyze Insulin Like Growth Factor 1 Receptor competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Like Growth Factor 1 Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Like Growth Factor 1 Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Like Growth Factor 1 Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Insulin Like Growth Factor 1 Receptor market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Insulin Like Growth Factor 1 Receptor industry.

Chapter 3: Detailed analysis of Insulin Like Growth Factor 1 Receptor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Insulin Like Growth Factor 1 Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Insulin Like Growth Factor 1 Receptor in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Insulin Like Growth Factor 1 Receptor Industry Trends Table 2. Insulin Like Growth Factor 1 Receptor Industry Drivers Table 3. Insulin Like Growth Factor 1 Receptor Industry Opportunities and Challenges Table 4. Insulin Like Growth Factor 1 Receptor Industry Restraints Table 5. Global Insulin Like Growth Factor 1 Receptor Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Insulin Like Growth Factor 1 Receptor Revenue Share by Company (2021-2026) Table 7. Global Insulin Like Growth Factor 1 Receptor Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Insulin Like Growth Factor 1 Receptor Sales Volume Share by Company (2021-2026) Table 9. Global Insulin Like Growth Factor 1 Receptor Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Insulin Like Growth Factor 1 Receptor Company Ranking, (2024-2026) & (USD Million) Table 11. Global Insulin Like Growth Factor 1 Receptor Key Company Manufacturing Base & Headquarters Table 12. Global Insulin Like Growth Factor 1 Receptor Company, Product Type & Application Table 13. Global Insulin Like Growth Factor 1 Receptor Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Insulin Like Growth Factor 1 Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of CT-707 Table 18. Significant Companies of BI-893923 Table 19. Significant Companies of ATL-1101 Table 20. Significant Companies of 1R-E1 Table 21. Significant Companies of Others Table 22. Global Insulin Like Growth Factor 1 Receptor Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 23. Global Insulin Like Growth Factor 1 Receptor Sales Volume by Type (2021-2026) & (W Units) Table 24. Global Insulin Like Growth Factor 1 Receptor Sales Volume by Type (2027-2032) & (W Units) Table 25. Global Insulin Like Growth Factor 1 Receptor Sales Volume Share by Type (2021-2026) Table 26. Global Insulin Like Growth Factor 1 Receptor Sales Volume Share by Type (2027-2032) Table 27. Global Insulin Like Growth Factor 1 Receptor Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Insulin Like Growth Factor 1 Receptor Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Insulin Like Growth Factor 1 Receptor Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Insulin Like Growth Factor 1 Receptor Sales Value Share by Type (2021-2026) Table 31. Global Insulin Like Growth Factor 1 Receptor Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital Table 33. Significant Companies of Clinic Table 34. Significant Companies of Others Table 35. Global Insulin Like Growth Factor 1 Receptor Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 36. Global Insulin Like Growth Factor 1 Receptor Sales Volume by Application (2021-2026) & (W Units) Table 37. Global Insulin Like Growth Factor 1 Receptor Sales Volume by Application (2027-2032) & (W Units) Table 38. Global Insulin Like Growth Factor 1 Receptor Sales Volume Share by Application (2021-2026) Table 39. Global Insulin Like Growth Factor 1 Receptor Sales Volume Share by Application (2027-2032) Table 40. Global Insulin Like Growth Factor 1 Receptor Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Insulin Like Growth Factor 1 Receptor Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Insulin Like Growth Factor 1 Receptor Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Insulin Like Growth Factor 1 Receptor Sales Value Share by Application (2021-2026) Table 44. Global Insulin Like Growth Factor 1 Receptor Sales Value Share by Application (2027-2032) Table 45. Global Insulin Like Growth Factor 1 Receptor Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 46. Global Insulin Like Growth Factor 1 Receptor Sales by Region (2021-2026) & (W Units) Table 47. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Region (2021-2026) Table 48. Global Insulin Like Growth Factor 1 Receptor Sales by Region (2027-2032) & (W Units) Table 49. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Region (2027-2032) Table 50. Global Insulin Like Growth Factor 1 Receptor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Insulin Like Growth Factor 1 Receptor Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Insulin Like Growth Factor 1 Receptor Sales Value Share by Region (2021-2026) Table 53. Global Insulin Like Growth Factor 1 Receptor Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Insulin Like Growth Factor 1 Receptor Sales Value Share by Region (2027-2032) Table 55. Global Insulin Like Growth Factor 1 Receptor Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Insulin Like Growth Factor 1 Receptor Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Insulin Like Growth Factor 1 Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. Global Insulin Like Growth Factor 1 Receptor Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 60. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2021-2026) Table 61. Global Insulin Like Growth Factor 1 Receptor Sales by Country (2027-2032) & (W Units) Table 62. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2027-2032) Table 63. Global Insulin Like Growth Factor 1 Receptor Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Insulin Like Growth Factor 1 Receptor Sales Value Market Share by Country (2021-2026) Table 65. Global Insulin Like Growth Factor 1 Receptor Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Insulin Like Growth Factor 1 Receptor Sales Value Market Share by Country (2027-2032) Table 67. Novartis AG Company Information Table 68. Novartis AG Business Overview Table 69. Novartis AG Insulin Like Growth Factor 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Novartis AG Insulin Like Growth Factor 1 Receptor Product Portfolio Table 71. Novartis AG Recent Development Table 72. Merck & Co., Inc. Company Information Table 73. Merck & Co., Inc. Business Overview Table 74. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 76. Merck & Co., Inc. Recent Development Table 77. Eli Lilly and Company Company Information Table 78. Eli Lilly and Company Business Overview Table 79. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product Portfolio Table 81. Eli Lilly and Company Recent Development Table 82. AstraZeneca Plc Company Information Table 83. AstraZeneca Plc Business Overview Table 84. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product Portfolio Table 86. AstraZeneca Plc Recent Development Table 87. ProteoThera, Inc. Company Information Table 88. ProteoThera, Inc. Business Overview Table 89. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 91. ProteoThera, Inc. Recent Development Table 92. PharmAbcine, Inc. Company Information Table 93. PharmAbcine, Inc. Business Overview Table 94. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 96. PharmAbcine, Inc. Recent Development Table 97. Merrimack Pharmaceuticals, Inc. Company Information Table 98. Merrimack Pharmaceuticals, Inc. Business Overview Table 99. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 101. Merrimack Pharmaceuticals, Inc. Recent Development Table 102. Insmed Incorporated Company Information Table 103. Insmed Incorporated Business Overview Table 104. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product Portfolio Table 106. Insmed Incorporated Recent Development Table 107. Immunomedics, Inc. Company Information Table 108. Immunomedics, Inc. Business Overview Table 109. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 111. Immunomedics, Inc. Recent Development Table 112. Genmab A/S Company Information Table 113. Genmab A/S Business Overview Table 114. Genmab A/S Insulin Like Growth Factor 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Genmab A/S Insulin Like Growth Factor 1 Receptor Product Portfolio Table 116. Genmab A/S Recent Development Table 117. F. Hoffmann-La Roche Ltd. Company Information Table 118. F. Hoffmann-La Roche Ltd. Business Overview Table 119. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 121. F. Hoffmann-La Roche Ltd. Recent Development Table 122. Bristol-Myers Squibb Company Company Information Table 123. Bristol-Myers Squibb Company Business Overview Table 124. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product Portfolio Table 126. Bristol-Myers Squibb Company Recent Development Table 127. Boehringer Ingelheim GmbH Company Information Table 128. Boehringer Ingelheim GmbH Business Overview Table 129. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product Portfolio Table 131. Boehringer Ingelheim GmbH Recent Development Table 132. Axelar AB Company Information Table 133. Axelar AB Business Overview Table 134. Axelar AB Insulin Like Growth Factor 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Axelar AB Insulin Like Growth Factor 1 Receptor Product Portfolio Table 136. Axelar AB Recent Development Table 137. Astellas Pharma Inc. Company Information Table 138. Astellas Pharma Inc. Business Overview Table 139. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 141. Astellas Pharma Inc. Recent Development Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Insulin Like Growth Factor 1 Receptor Distributors List Table 145. Insulin Like Growth Factor 1 Receptor Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Insulin Like Growth Factor 1 Receptor Product Image Figure 2. Global Insulin Like Growth Factor 1 Receptor Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Like Growth Factor 1 Receptor Sales Value (2021-2032) & (US$ Million) Figure 4. Global Insulin Like Growth Factor 1 Receptor Sales (2021-2032) & (W Units) Figure 5. Global Insulin Like Growth Factor 1 Receptor Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Insulin Like Growth Factor 1 Receptor Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. CT-707 Image Figure 10. BI-893923 Image Figure 11. ATL-1101 Image Figure 12. 1R-E1 Image Figure 13. Others Image Figure 14. Global Insulin Like Growth Factor 1 Receptor Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Insulin Like Growth Factor 1 Receptor Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Insulin Like Growth Factor 1 Receptor Sales Volume Share by Type (2021-2032) Figure 17. Global Insulin Like Growth Factor 1 Receptor Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Insulin Like Growth Factor 1 Receptor Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Insulin Like Growth Factor 1 Receptor Sales Value Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Clinic Image Figure 22. Others Image Figure 23. Global Insulin Like Growth Factor 1 Receptor Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Insulin Like Growth Factor 1 Receptor Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Insulin Like Growth Factor 1 Receptor Sales Volume Share by Application (2021-2032) Figure 26. Global Insulin Like Growth Factor 1 Receptor Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Insulin Like Growth Factor 1 Receptor Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Insulin Like Growth Factor 1 Receptor Sales Value Share by Application (2021-2032) Figure 29. Global Insulin Like Growth Factor 1 Receptor Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 30. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Insulin Like Growth Factor 1 Receptor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Insulin Like Growth Factor 1 Receptor Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Insulin Like Growth Factor 1 Receptor Sales Value (2021-2032) & (US$ Million) Figure 34. North America Insulin Like Growth Factor 1 Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Insulin Like Growth Factor 1 Receptor Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Insulin Like Growth Factor 1 Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Insulin Like Growth Factor 1 Receptor Sales Value (2021-2032) & (US$ Million) Figure 40. South America Insulin Like Growth Factor 1 Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Insulin Like Growth Factor 1 Receptor Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Insulin Like Growth Factor 1 Receptor Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • CT-707
  • BI-893923
  • ATL-1101
  • 1R-E1
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Novartis AG
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • AstraZeneca Plc
  • ProteoThera, Inc.
  • PharmAbcine, Inc.
  • Merrimack Pharmaceuticals, Inc.
  • Insmed Incorporated
  • Immunomedics, Inc.
  • Genmab A/S
  • F. Hoffmann-La Roche Ltd.
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim GmbH
  • Axelar AB
  • Astellas Pharma Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Insulin Like Growth Factor 1 Receptor Sales Value (2021-2032)
  4. 1.2.2 Global Insulin Like Growth Factor 1 Receptor Sales Volume (2021-2032)
  5. 1.2.3 Global Insulin Like Growth Factor 1 Receptor Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Insulin Like Growth Factor 1 Receptor Market Dynamics
  1. 2.1 Insulin Like Growth Factor 1 Receptor Industry Trends
  2. 2.2 Insulin Like Growth Factor 1 Receptor Industry Drivers
  3. 2.3 Insulin Like Growth Factor 1 Receptor Industry Opportunities and Challenges
  4. 2.4 Insulin Like Growth Factor 1 Receptor Industry Restraints
3 Insulin Like Growth Factor 1 Receptor Market by Company
  1. 3.1 Global Insulin Like Growth Factor 1 Receptor Company Revenue Ranking in 2025
  2. 3.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Company (2021-2026)
  3. 3.3 Global Insulin Like Growth Factor 1 Receptor Sales Volume by Company (2021-2026)
  4. 3.4 Global Insulin Like Growth Factor 1 Receptor Average Price by Company (2021-2026)
  5. 3.5 Global Insulin Like Growth Factor 1 Receptor Company Ranking (2024-2026)
  6. 3.6 Global Insulin Like Growth Factor 1 Receptor Company Manufacturing Base and Headquarters
  7. 3.7 Global Insulin Like Growth Factor 1 Receptor Company Product Type and Application
  8. 3.8 Global Insulin Like Growth Factor 1 Receptor Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Insulin Like Growth Factor 1 Receptor Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Insulin Like Growth Factor 1 Receptor Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Insulin Like Growth Factor 1 Receptor Market by Type
  1. 4.1 Insulin Like Growth Factor 1 Receptor Type Introduction
  2. 4.1.1 CT-707
  3. 4.1.2 BI-893923
  4. 4.1.3 ATL-1101
  5. 4.1.4 1R-E1
  6. 4.1.5 Others
  7. 4.2 Global Insulin Like Growth Factor 1 Receptor Sales Volume by Type
  8. 4.2.1 Global Insulin Like Growth Factor 1 Receptor Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Insulin Like Growth Factor 1 Receptor Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Insulin Like Growth Factor 1 Receptor Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Insulin Like Growth Factor 1 Receptor Sales Value by Type
  12. 4.3.1 Global Insulin Like Growth Factor 1 Receptor Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Insulin Like Growth Factor 1 Receptor Sales Value by Type (2021-2032)
  14. 4.3.3 Global Insulin Like Growth Factor 1 Receptor Sales Value Share by Type (2021-2032)
5 Insulin Like Growth Factor 1 Receptor Market by Application
  1. 5.1 Insulin Like Growth Factor 1 Receptor Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Insulin Like Growth Factor 1 Receptor Sales Volume by Application
  6. 5.2.1 Global Insulin Like Growth Factor 1 Receptor Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Insulin Like Growth Factor 1 Receptor Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Insulin Like Growth Factor 1 Receptor Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Insulin Like Growth Factor 1 Receptor Sales Value by Application
  10. 5.3.1 Global Insulin Like Growth Factor 1 Receptor Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Insulin Like Growth Factor 1 Receptor Sales Value by Application (2021-2032)
  12. 5.3.3 Global Insulin Like Growth Factor 1 Receptor Sales Value Share by Application (2021-2032)
6 Insulin Like Growth Factor 1 Receptor Regional Sales and Value Analysis
  1. 6.1 Global Insulin Like Growth Factor 1 Receptor Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Insulin Like Growth Factor 1 Receptor Sales by Region (2021-2032)
  3. 6.2.1 Global Insulin Like Growth Factor 1 Receptor Sales by Region: 2021-2026
  4. 6.2.2 Global Insulin Like Growth Factor 1 Receptor Sales by Region (2027-2032)
  5. 6.3 Global Insulin Like Growth Factor 1 Receptor Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Insulin Like Growth Factor 1 Receptor Sales Value by Region (2021-2032)
  7. 6.4.1 Global Insulin Like Growth Factor 1 Receptor Sales Value by Region: 2021-2026
  8. 6.4.2 Global Insulin Like Growth Factor 1 Receptor Sales Value by Region (2027-2032)
  9. 6.5 Global Insulin Like Growth Factor 1 Receptor Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Insulin Like Growth Factor 1 Receptor Sales Value (2021-2032)
  12. 6.6.2 North America Insulin Like Growth Factor 1 Receptor Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Insulin Like Growth Factor 1 Receptor Sales Value (2021-2032)
  15. 6.7.2 Europe Insulin Like Growth Factor 1 Receptor Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Insulin Like Growth Factor 1 Receptor Sales Value (2021-2032)
  21. 6.9.2 South America Insulin Like Growth Factor 1 Receptor Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales Value Share by Country, 2025 VS 2032
7 Insulin Like Growth Factor 1 Receptor Country-level Sales and Value Analysis
  1. 7.1 Global Insulin Like Growth Factor 1 Receptor Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Insulin Like Growth Factor 1 Receptor Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2032)
  4. 7.3.1 Global Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026)
  5. 7.3.2 Global Insulin Like Growth Factor 1 Receptor Sales by Country (2027-2032)
  6. 7.4 Global Insulin Like Growth Factor 1 Receptor Sales Value by Country (2021-2032)
  7. 7.4.1 Global Insulin Like Growth Factor 1 Receptor Sales Value by Country (2021-2026)
  8. 7.4.2 Global Insulin Like Growth Factor 1 Receptor Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Insulin Like Growth Factor 1 Receptor Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Insulin Like Growth Factor 1 Receptor Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Insulin Like Growth Factor 1 Receptor Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Insulin Like Growth Factor 1 Receptor Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Insulin Like Growth Factor 1 Receptor Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 Merck & Co., Inc.
  8. 8.2.1 Merck & Co., Inc. Company Information
  9. 8.2.2 Merck & Co., Inc. Business Overview
  10. 8.2.3 Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  12. 8.2.5 Merck & Co., Inc. Recent Developments
  13. 8.3 Eli Lilly and Company
  14. 8.3.1 Eli Lilly and Company Company Information
  15. 8.3.2 Eli Lilly and Company Business Overview
  16. 8.3.3 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product Portfolio
  18. 8.3.5 Eli Lilly and Company Recent Developments
  19. 8.4 AstraZeneca Plc
  20. 8.4.1 AstraZeneca Plc Company Information
  21. 8.4.2 AstraZeneca Plc Business Overview
  22. 8.4.3 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product Portfolio
  24. 8.4.5 AstraZeneca Plc Recent Developments
  25. 8.5 ProteoThera, Inc.
  26. 8.5.1 ProteoThera, Inc. Company Information
  27. 8.5.2 ProteoThera, Inc. Business Overview
  28. 8.5.3 ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  30. 8.5.5 ProteoThera, Inc. Recent Developments
  31. 8.6 PharmAbcine, Inc.
  32. 8.6.1 PharmAbcine, Inc. Company Information
  33. 8.6.2 PharmAbcine, Inc. Business Overview
  34. 8.6.3 PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  36. 8.6.5 PharmAbcine, Inc. Recent Developments
  37. 8.7 Merrimack Pharmaceuticals, Inc.
  38. 8.7.1 Merrimack Pharmaceuticals, Inc. Company Information
  39. 8.7.2 Merrimack Pharmaceuticals, Inc. Business Overview
  40. 8.7.3 Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  42. 8.7.5 Merrimack Pharmaceuticals, Inc. Recent Developments
  43. 8.8 Insmed Incorporated
  44. 8.8.1 Insmed Incorporated Company Information
  45. 8.8.2 Insmed Incorporated Business Overview
  46. 8.8.3 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product Portfolio
  48. 8.8.5 Insmed Incorporated Recent Developments
  49. 8.9 Immunomedics, Inc.
  50. 8.9.1 Immunomedics, Inc. Company Information
  51. 8.9.2 Immunomedics, Inc. Business Overview
  52. 8.9.3 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  54. 8.9.5 Immunomedics, Inc. Recent Developments
  55. 8.10 Genmab A/S
  56. 8.10.1 Genmab A/S Company Information
  57. 8.10.2 Genmab A/S Business Overview
  58. 8.10.3 Genmab A/S Insulin Like Growth Factor 1 Receptor Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Genmab A/S Insulin Like Growth Factor 1 Receptor Product Portfolio
  60. 8.10.5 Genmab A/S Recent Developments
  61. 8.11 F. Hoffmann-La Roche Ltd.
  62. 8.11.1 F. Hoffmann-La Roche Ltd. Company Information
  63. 8.11.2 F. Hoffmann-La Roche Ltd. Business Overview
  64. 8.11.3 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Product Portfolio
  66. 8.11.5 F. Hoffmann-La Roche Ltd. Recent Developments
  67. 8.12 Bristol-Myers Squibb Company
  68. 8.12.1 Bristol-Myers Squibb Company Company Information
  69. 8.12.2 Bristol-Myers Squibb Company Business Overview
  70. 8.12.3 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product Portfolio
  72. 8.12.5 Bristol-Myers Squibb Company Recent Developments
  73. 8.13 Boehringer Ingelheim GmbH
  74. 8.13.1 Boehringer Ingelheim GmbH Company Information
  75. 8.13.2 Boehringer Ingelheim GmbH Business Overview
  76. 8.13.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product Portfolio
  78. 8.13.5 Boehringer Ingelheim GmbH Recent Developments
  79. 8.14 Axelar AB
  80. 8.14.1 Axelar AB Company Information
  81. 8.14.2 Axelar AB Business Overview
  82. 8.14.3 Axelar AB Insulin Like Growth Factor 1 Receptor Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Axelar AB Insulin Like Growth Factor 1 Receptor Product Portfolio
  84. 8.14.5 Axelar AB Recent Developments
  85. 8.15 Astellas Pharma Inc.
  86. 8.15.1 Astellas Pharma Inc. Company Information
  87. 8.15.2 Astellas Pharma Inc. Business Overview
  88. 8.15.3 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  90. 8.15.5 Astellas Pharma Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Insulin Like Growth Factor 1 Receptor Value Chain Analysis
  2. 9.1.1 Insulin Like Growth Factor 1 Receptor Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Insulin Like Growth Factor 1 Receptor Sales Mode & Process
  6. 9.2 Insulin Like Growth Factor 1 Receptor Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Insulin Like Growth Factor 1 Receptor Distributors
  9. 9.2.3 Insulin Like Growth Factor 1 Receptor Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst